For research teamsHelp me find a study
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 6,565-6,576 of 10,592
Drug study icon
WithdrawnNCT05661669

Ketamine for the Treatment for Addiction in the ED

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Brigham and Women's Hospital
Condition
Addiction
View study
Drug study icon
CompletedNCT04177706

Ketamine for Addiction and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression, Addiction
View study
Drug study icon
CompletedNCT04944017

Ketamine for Depression in Parkinson's Disease

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand how people respond to brain scans or other body measurements in practice and what may need to be adjusted.

In United States
DepressionDrugFrom 40 Years to 80 Years
Countries
United States
Sponsor
Yale University
Condition
Depression
View study
Drug study icon
TerminatedNCT03395314

Ketamine in Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityDrugFrom 21 Years to 60 Years
Countries
United States
Sponsor
Yale University
Condition
Suicidality
View study
Drug study icon
CompletedNCT01700829

Ketamine in the Treatment of Suicidal Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, SuicidalityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression, Suicidality
View study
Drug study icon
CompletedNCT02579928

Ketamine Infusion for Adolescent Depression and Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, AnxietyDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Yale University
Condition
Depression, Anxiety
View study
Drug study icon
CompletedNCT04322968

Ketamine Infusion for Comorbid PTSD and Chronic Pain

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Ann Arbor Healthcare System
Condition
PTSD
View study
Drug study icon
CompletedNCT01349231

Ketamine Infusion for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
OCD
View study
Drug study icon
CompletedNCT03088384

Ketamine Infusion Therapy for PTSD in Combat Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Klarisana Physician Services PLLC
Condition
PTSD
View study
Drug study icon
CompletedNCT03947099

Ketamine Infusion Therapy for PTSD in Paramedics

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSD, AnxietyDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
Klarisana Physician Services PLLC
Condition
PTSD, Anxiety
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.